Navigation Links
Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting

asive bladder cancer, that trials evaluating the effects of satraplatin in combination with radiation therapy, in combination with other cancer therapies and in a number of cancer types are underway or planned, that SPI-1620 is expected to enter clinical trials later this year and any statements that relate to the intent, belief, plans or expectations of Spectrum or its management, or that are not a statement of historical fact. Risks that could cause actual results to differ include the possibility that our existing and new drug candidates, may not prove safe or effective, the possibility that our existing and new drug candidates may not receive approval from the FDA, and other regulatory agencies in a timely manner or at all, the possibility that our existing and new drug candidates, if approved, may not be more effective, safer or more cost efficient than competing drugs, the possibility that our efforts to acquire or in- license and develop additional drug candidates may fail, our lack of revenues, our limited marketing experience, our dependence on third parties for clinical trials, manufacturing, distribution and quality control and other risks that are described in further detail in the Company's reports filed with the Securities and Exchange Commission. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this press release except as required by law.

    COMPANY CONTACTS                    MEDIA CONTACT

    Russell Skibsted                    Susan Neath

    SVP & Chief Business Officer        Porter Novelli Life Sciences

                                        619-849-6007

    Paul Arndt

    Manager, Investor Relations

    949-788-6700

CONTACT: Russell Skibsted, SVP & Chief Business Officer, or Paul ArndtManager, Investor Relations, both of Spectrum Pharmaceuticals, Inc.,+1-949-788-6700; or Media Contact, Susan Neath of Porter Novelli LifeScienc
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:5/4/2015)... 2015 Unchained Labs, a refreshingly new biologic ... PEGS conference and launches the UNit — the first ... The Essential Protein Engineering Summit takes place in ... The UNit lets drug discovery researchers look at more ... Its 7 applications, 144 sample a day throughput and ...
(Date:5/4/2015)... , May 4, 2015 The Pharmacy ... Survey, which confirmed that pharmacy has shifted toward a ... active pharmacists and managers, there is an incredible opportunity ... in the next decade. In a ... site, Essential Insights , Eden Sulzer, director ...
(Date:5/4/2015)... 4, 2015  Verus Healthcare, Inc. recently completed its ... Care Club in 2012.  Since that original acquisition, the ... medical equipment (DME) industry by 1,000%.  Verus Healthcare now ... supply needs and processes nearly 14,000 new orders per ... years ago, the systems and processes weren,t in place ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 3Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2
... Cyberonics, Inc. (Nasdaq: CYBX ) today announced ... Browne, Chief Financial Officer, will present at the 22nd Annual ... November 30, 2010 at 1:30 PM ET.  The conference session ... will be presented.  Piper Jaffray will host a webcast of ...
... /PRNewswire-FirstCall/ -- AVANIR ... the pricing of an underwritten public offering of 20,000,000 shares ... per share.  The offering is expected to close on or ... addition, AVANIR has granted the underwriters a 30-day option to ...
Cached Medicine Technology:Cyberonics to Present at 22nd Annual Piper Jaffray Health Care Conference 2AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock 3
(Date:5/4/2015)... Sheltering Arms announced that it has acquired ... Mother Hale Learning Center meets a tremendous need in ... Arms will begin operating the site immediately and all ... center. , Opened in 2006, the Mother Hale Learning ... years, many of whom come from high-need backgrounds. Guided ...
(Date:5/4/2015)... MT (PRWEB) May 04, 2015 New ... with Care to Care, LLC to manage outpatient advanced ... help New West Medicare ensure its members are provided ... unnecessary radiation. , Working closely with New West Medicare’s ... promoting the safe use of advanced imaging and provide ...
(Date:5/4/2015)... Elisabeth Rosenthal’s article* on “balance ... showed the healthcare fraternity as well as patients ... downside of balance billing. In definition, balance billing ... a patient for the difference between what the ... the provider chooses to charge. Rosenthal’s article talks ...
(Date:5/4/2015)... 2015 In response to the ... Task Force (USPSTF), Strategic Radiology® (SR®) fully aligns ... Obstetricians and Gynecologists (ACOG), the American College Of ... Cancer Society (ACS), American College of Radiology (ACR), ... recommend regular screening mammography for women beginning at ...
(Date:5/4/2015)... World T.E.A.M. Sports’ best-attended Face of ... last decade arrived in this historic Civil War community ... from the Pentagon in Arlington, Virginia. The annual ride ... able-bodied participants work together to successfully complete the journey. ... commitment and sacrifices by military veterans in their defensive ...
Breaking Medicine News(10 mins):Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4
... a product containing the drug estazolam, which might make the ... // ,Estazolam belongs to benzodiazepines class of drugs, ... it may have a number of side effects like loss ... not legal to sell it in Canada. ,Hence, try ...
... There has been a major outbreak of pneumonia in the ... // ,The outbreak in the Downtown Eastside has ... month. ,In a November 30 memo, David Butcher, ... staff that the Vancouver outbreak was severely limiting the availability ...
... become an integral part of the cocktail of drugs consumed by ... ice are marijuana, ketamine, heroin and other illicit drugs. ,Ice ... when they have report to work. ,After excessive stimulation by ... which they usually smoke ice to get over it. ,Paul ...
... taken from primary tumor biopsies is highly associated with ... to researchers who// say this protein profile could help ... is likely to metastasize. ,In the December ... of one unidentified protein and under-expression of another is ...
... by team of senior scientists warns that many tests of drugs ... prototype medicine will work on humans. ,The British Medical ... have found that animal studies agreed with human trials in just ... that the high-profile London drug trial that left six men ill ...
... Health urges people with history of unprotected sex to ... local HIV transmission.// The announcement being the first case ... officials, on Thursday uncovered two clusters of HIV infections, ... samples by government scientists. They said that both the ...
Cached Medicine News:Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 2Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 3Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 4Health News:Many Drug Tests on Animals are Badly Flawed, a Study Warns 2
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
The cementless biomEx cup can be used with both cemented and cementless femoral stems....
The Secur-Fit cups incorporate enhancements derived from years of clinical, radiographic, and implant retrieval observations....
Medicine Products: